FDA Approves Novel Medication for Smoking Cessation The active ingredient
FDA Approves Novel Medication for Smoking Cessation
The active ingredient in Chantix, varenicline tartrate, is a new molecular entity that received a priority FDA review because of its significant potential benefit to public health.